Xilio Therapeutics Share Price (NASDAQ: XLO)
$0.68
Live
Last updated on
Check the interactive Xilio Therapeutics Stock chart to analyse performance
Xilio Therapeutics, Inc. Key Stats
Check Xilio Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Xilio Therapeutics Stock including INR - Dollar returns
The Xilio Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Xilio Therapeutics investment value today
Current value as on today
₹90,177
Returns
Returns from Xilio Therapeutics Stock
Dollar Returns*
₹5,177 (+5.18%)
Indian investors sentiment towards Xilio Therapeutics Stock
Global Institutional Holdings in Xilio Therapeutics, Inc.
Name
Holdings %
Bain Capital Life Sciences Investors, LLC
8.81%
Merck & Co Inc
2.86%
Takeda Pharmaceutical Co Ltd
2.85%
Morgan Stanley - Brokerage Accounts
2.23%
Vanguard Group Inc
2.22%
FMR Inc
1.71%
Analyst Recommendation on Xilio Therapeutics Stock
Buy
85%Buy
14%Hold
0%Sell
Based on 7 Wall street analysts offering stock ratings for Xilio Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Xilio Therapeutics Share Price Target
What analysts predicted
Upside of 488.24%
Target:
$4.00
Current:
$0.68
Xilio Therapeutics share price target is $4.00, a slight Upside of 488.24% compared to current price of $0.68 as per analysts' prediction.
Xilio Therapeutics Stock Insights
Price Movement
In the last 3 months, XLO stock has moved down by -29.3%XLO vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.5% return, outperforming this stock by 72.7%XLO vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.3% return, outperforming this stock by 186.0%Price to Sales
ForXLO every $1 of sales, investors are willing to pay $2.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.8 for every $1 of sales.
Xilio Therapeutics Technicals Summary
Sell
Neutral
Buy
Xilio Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Xilio Therapeutics, Inc. Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -1.7% | -24.81% | -15.23% | -69.59% | -95.74% |
 | 3.77% | -17.64% | -51.18% | -2.19% | -7.17% |
 | -0.02% | 10.33% | 51.07% | 81.16% | 24.14% |
 | -16.39% | -18.24% | -20.49% | 39.42% | 40.54% |
 | 33.05% | 83.22% | 57.52% | 115.32% | 240.85% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.61 | -2.78 | -0.32 | NA | 0.14 |
| 14.79 | 14.79 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.69 | 27.69 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $35.5M | -95.74% | NA | 0.0% |
| Buy | $62.2B | -7.17% | 14.79 | 31.37% |
| NA | $36.8B | 24.14% | NA | -3.89% |
| Buy | $99.8B | 40.54% | 27.69 | 31.86% |
| Buy | $59.1B | 240.85% | NA | -12.96% |
About Xilio Therapeutics, Inc.
Key Management of Xilio Therapeutics, Inc.
Important FAQs about investing in XLO Stock from India :
What is Xilio Therapeutics share price today?
Xilio Therapeutics share price today is $0.68 as on . Xilio Therapeutics share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.
What is the 52 week high and 52 week low for Xilio Therapeutics share?
Xilio Therapeutics share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Xilio Therapeutics stock price today i.e. is trending at $0.68, lower by 60% versus the 52 week high.
How to invest in Xilio Therapeutics Stock (XLO) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Xilio Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xilio Therapeutics Shares that will get you 2.2059 shares as per Xilio Therapeutics share price of $0.68 per share as on August 30, 2025 at 12:34 am IST.
What is the minimum amount required to buy Xilio Therapeutics Stock (XLO) from India?
Indian investors can start investing in Xilio Therapeutics (XLO) shares with as little as ₹88.167 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.67 in Xilio Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 29, 2025).
Based on Xilio Therapeutics share’s latest price of $0.68 as on August 30, 2025 at 12:34 am IST, you will get 14.7059 shares of Xilio Therapeutics. Learn more about
fractional shares .
What are the returns that Xilio Therapeutics has given to Indian investors in the last 5 years?
Xilio Therapeutics stock has given -95.74% share price returns and 20.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Sunlands Online Education Group$9.70
-1.22%
Immunocore Holdings Plc-adr$31.95
-0.9%
1-800-flowers.com, Inc.$5.54
-1.07%
Skillsoft Corp$15.44
-0.06%
Xpel Inc$37.16
-1.75%
Stitch Fix, Inc. (class A Shares)$5.36
-3.6%
Papa John's International Inc.$48.27
+1.26%
America's Car-mart Inc$45.70
-1.68%
Netstreit Corp$18.27
+0.38%